4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Nerve Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goshima, Y; Hasegawa, M; Hensley, K; Masukawa, D; Nagai, J; Ohshima, T; Togashi, K; Tonouchi, A | 1 |
1 other study(ies) available for 4-phenyl-1,2,3,6-tetrahydropyridine and Nerve Degeneration
Article | Year |
---|---|
Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopaminergic Neurons; Intercellular Signaling Peptides and Proteins; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Motor Activity; Neostriatum; Nerve Degeneration; Nerve Tissue Proteins; Parkinson Disease; Phosphorylation; Substantia Nigra; Suppression, Genetic | 2019 |